Can Organic Solvent Nanofiltration (OSN) be considered green? Is OSN greener than other downstream processing technologies? These are the two main questions addressed critically in the present review. Further questions dealt with in the review are as follows: What is the carbon footprint associated with the fabrication and disposal of membrane modules? How much solvent has to be processed by OSN before the environmental burden of OSN is less than the environmental burden of alternative technologies? What are the main challenges for improving the sustainability of OSN? How can the concept of Quality by Design (QbD) improve and assist the progress of the OSN field? Does the scale have an effect on the sustainability of membrane processes? The green aspects of OSN membrane fabrication, processes development and scale-up as well as the supporting concept of QbD, and solvent recovery technologies are critically assessed and future research directions are given, in this review. Gyorgy Szekely Gyorgy received his MSc degree in Chemical Engineering from the Technical University of Budapest, and he earned his PhD degree in Chemistry under Marie Curie Actions from the Technical University of Dortmund. He worked as an Early Stage Researcher in Hovione PharmaScience and an IAESTE Fellow at the University of Tokyo. He is currently a Research Associate in Imperial College London. His multidisciplinary professional background covers supramolecular chemistry, organic and analytical chemistry, molecular recognition, molecular imprinting, process development, nanofiltration and pharmaceutical impurity scavenging. He is the Secretary General of the Marie Curie Fellows Association and a Member of the Royal Society of Chemistry.
In this review, thermally induced phase separation (TIPS) and electrospinning methods for preparation of fluoropolymer membranes are assessed, particularly for the polyvinylidene fluoride (PVDF) and polyethylene chlorotrifluoroethylene membranes. This review focuses on controlling the membrane morphology from the thermodynamic and kinetic perspectives to understand the relationship between the membrane morphology and fabrication parameters. In addition, the current status of the nonsolvent induced phase separation (NIPS) method and the combined NIPS-TIPS (N-TIPS) method, which is a new emerging fabrication method, are discussed. The past literature data are compiled and an upperbound curve (permeability vs. tensile strength) is proposed for the TIPS-prepared PVDF membranes. Furthermore, the key parameters that control and determine the membrane morphology when using the electrospinning method are reviewed. Exploiting the unique advantages of the electrospinning method, our current understanding in controlling and finetuning the PVDF crystal polymorphism (i.e., b-phase) is critically assessed. V C 2015 American Institute of Chemical Engineers AIChE J, 62: 461-490, 2016 Figure 15. Cross section of 40 wt % PVDF/GBL hollow fiber membranes: (left) with LiCl additive, (middle) with glycerol additive, (right) with LiCl and glycerol additives.Formation of such fine pores nearly doubled the flux without losing mechanical strength. 28 481 TEM images of 4 wt % PVP nanofibers from different compositions of EtOH/DMF: (b) 65/35, (c) 50/50, (d) 35/65, and (e) SEM image of 4 wt % PVP nanofibers using EtOH/DMF (50/50). 146 482
A novel end-group crosslinked anion exchange membrane showed the connecting ionic-clustered morphology that improved electrochemical performances and durability for alkaline fuel cell operation.
Membrane processes suffer limitations such as low product yield and high solvent consumption, hindering their widespread application in the pharmaceutical and fine chemicals industries. In the present work, the authors propose an efficient purification methodology employing a two-stage cascade configuration coupled to an adsorptive solvent recovery unit, which addresses the two limitations. The process has been validated on purification of active pharmaceutical ingredient (API) from genotoxic impurity (GTI) using organic solvent nanofiltration (OSN). The model system selected for study comprises roxithromycin macrolide antibiotic (Roxi) with 4-dimethylaminopyridine (DMAP) and ethyl tosylate (EtTS) as API and GTIs, respectively. By implementing a two-stage cascade configuration for membrane diafiltration, the process yield was increased from 58% to 95% while maintaining less than 5 ppm GTI in the final solution. Through this yield enhancement, the membrane process has been "revamped" from an unfeasible process to a highly competitive unit operation when compared to other traditional processes. The advantage of size exclusion membranes over other separation techniques has been illustrated by the simultaneous removal of two GTIs from different chemical classes. In addition, a solvent recovery step has been assessed using charcoal as a non-selective adsorbent, and it has been shown that pure solvent can be recovered from the permeate. Considering the costs of solvent, charcoal, and waste disposal, it was concluded that 70% solvent recovery is the cost-optimum point. Conventional single-stage diafiltration (SSD) and two-stage diafiltration (TSD) configurations were compared in terms of green metrics such as cost, mass and solvent intensity, and energy consumption. It was calculated that implementation of TSD, depending on the batch scale, can achieve up to 92% cost saving while reducing the mass and solvent intensity up to 73%. In addition, the advantage of adsorptive solvent recovery has been assessed revealing up to 96% energy reduction compared to distillation and a 70% reduction of CO 2 footprint.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.